UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination

Microbiology spectrum, 2022-04, Vol.10 (2), p.e0041122-e0041122

2022

Volltextzugriff (PDF)

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Infectious diseases and therapy, 2022-04, Vol.11 (2), p.661-682

2022

Volltextzugriff (PDF)

Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model

Microbiology spectrum, 2023-08, Vol.11 (4), p.e0034023-e0034023

2023

Volltextzugriff (PDF)

Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms

Microbiology spectrum, 2023-06, Vol.11 (3), p.e0491822-e0491822

2023

Volltextzugriff (PDF)

Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection

Microbiology spectrum, 2021-10, Vol.9 (2), p.e0046421-e0046421

2021

Volltextzugriff (PDF)

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

Microbiology spectrum, 2023-02, Vol.11 (1), p.e0264722-e0264722

2023

Volltextzugriff (PDF)

Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

Antimicrobial agents and chemotherapy, 2024-04, Vol.68 (4), p.e0138823

2024

Volltextzugriff (PDF)

Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections

Microbiology spectrum, 2024-02, Vol.12 (2), p.e0310823-e0310823

2024

Volltextzugriff (PDF)

Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistant Stenotrophomonas maltophilia

Pharmacotherapy, 2023-08, Vol.43 (8), p.833-846

2023

Volltextzugriff (PDF)

Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0072823-e0072823

2023

Volltextzugriff (PDF)

Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection

Antimicrobial agents and chemotherapy, 2022-10, Vol.66 (10), p.e0064622-e0064622

2022

Volltextzugriff (PDF)

Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections

Pharmacotherapy, 2023-06, Vol.43 (6), p.502-513

2023

Volltextzugriff (PDF)

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e1444-e1455

2023

Volltextzugriff (PDF)

Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report

Open forum infectious diseases, 2022-04, Vol.9 (4), p.ofac092

2022

Volltextzugriff (PDF)

Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms

Microbiology spectrum, 2024-04, Vol.12 (4), p.e0321223-e0321223

2024

Volltextzugriff (PDF)

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

Open forum infectious diseases, 2023-03, Vol.10 (3), p.ofad034-ofad034

2023

Volltextzugriff (PDF)

Penicillin allergy reassessment for treatment improvement: A dental office tool to support appropriate penicillin allergy labeling

The Journal of the American Dental Association (1939), 2024-05, Vol.155 (5), p.379

2024

Volltextzugriff (PDF)

Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model

Antimicrobial agents and chemotherapy, 2023-06, Vol.67 (6), p.e0131722-e0131722

2023

Volltextzugriff (PDF)

Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0057823-e0057823

2023

Volltextzugriff (PDF)

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese

Open forum infectious diseases, 2023-09, Vol.10 (9), p.ofad454-ofad454

2023

Volltextzugriff (PDF)

Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens

Microbiology spectrum, 2024-07, p.e0042724

2024

Volltextzugriff (PDF)

Post‐graduate pharmacy fellowships: The current state of affairs

JAACP : Journal of the American College of Clinical Pharmacy, 2023-02, Vol.6 (2), p.145-153

2023

Volltextzugriff (PDF)

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

Infectious diseases and therapy, 2022-10, Vol.11 (5), p.1965-1980

2022

Volltextzugriff (PDF)

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Microbiology
(17)
Humans
(13)
Anti-Bacterial Agents - Pharmacology
(9)
Microbial Sensitivity Tests
(9)
Pharmacology & Pharmacy
(8)
Pseudomonas Aeruginosa
(8)
Research Article
(8)
Antimicrobial Chemotherapy
(7)
Bacteriophage
(6)
Bacteriophages
(6)
Infectious Diseases
(6)
Retrospective Studies
(6)
Anti-Bacterial Agents - Adverse Effects
(5)
Anti-Bacterial Agents - Therapeutic Use
(5)
Biofilms
(5)
Adult
(4)
Antibiotics
(4)
Beta Lactamases
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model

Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms

Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections

Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistant Stenotrophomonas maltophilia

Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models

Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection

Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report

Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022

Penicillin allergy reassessment for treatment improvement: A dental office tool to support appropriate penicillin allergy labeling

Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model

Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese

Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens

Post‐graduate pharmacy fellowships: The current state of affairs

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

Aktive Filter

Suchergebnisse filtern